Methazolamide NDC 27241-246

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-246Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0246Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-246-01	27241024601	100 TABLET in 1 BOTTLE (27241-246-01)Marketed from Feb 9, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methazolamide
Generic name (nonproprietary): methazolamide
Active ingredients: Methazolamide — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Ajanta Pharma USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217408
Marketing start: Feb 9, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 27241-246_a9e7c170-285c-4591-9a4f-0166806831dcSPL ID a9e7c170-285c-4591-9a4f-0166806831dcSPL set ID 879a3c78-24dd-41f9-8fce-5f3166b0e2f4RxCUI 197939, 197940UNII W733B0S9SDUPC 0327241246012, 0327241247019

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241024601 followed by a unit qualifier and the quantity

Package 27241-0246-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 10, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methazolamide Tablets, USP are indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217408

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217408
Product	Strength	Form · route	Labeler	Product NDC
Methazolamide	Methazolamide 50 mg/1	TabletOral	Ajanta Pharma USA Inc.	27241-247